AGE

, 31:199 | Cite as

Frontiers proposal. National Institute on Aging “bench to bedside: estrogen as a case study”

Article

Abstract

On 28–29 September 2004, the National Institute on Aging (NIA) convened scientists for a workshop on the aging female brain focused on translating into clinical practice discoveries concerning estrogens and progestogens. Workshop objectives were to examine effects of estrogen and progestogen on brain and cognitive function in relation to aging, to examine consistencies and apparent discrepancies between Women’s Health Initiative Memory Study findings and other research on cognitive function, to determine whether additional hormone interventions could be developed in this area, and to offer advice on design of clinical trials for other interventions that might ameliorate cognitive aging. Following the workshop, participants joined by other interested scientists organized into regional work groups to continue the dialogue begun in Bethesda and to propose recommendations for NIA. The resulting recommendations, referred to as the “Frontiers Proposal for Estrogen and Cognitive Aging”, acknowledge the persistence of critical gaps in our understanding of how decline in ovarian steroid secretion during reproductive aging and use of ovarian steroid hormone therapy affect normal brain function and risk for late-life neurodegenerative disorders such as Alzheimer’s disease. There is a pressing need for preclinical, human, and integrated studies on the relationship between the menopausal transition and midlife exposures to estrogens, progestogens and related compounds, and risks for age-associated cognitive disorders. Research is also needed on better predictors of adverse cognitive outcomes, valid biomarkers for risks associated with hormone therapy use, enhanced tools for monitoring brain function and disease progression, and novel forms of therapy for improving long-term cognitive outcomes.

Keywords

Aging Alzheimer’s disease Cognition Dementia Estrogen Menopause Progestogen 

References

  1. Adams MM, Shah RA, Janssen WG, Morrison JH (2001) Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc Natl Acad Sci USA 98:8071–8076. doi: 10.1073/pnas.141215898 PubMedCrossRefGoogle Scholar
  2. Anderson GL, Judd HL, Kaunitz AM et al (2003) Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA 290:1739–1748. doi: 10.1001/jama.290.13.1739 PubMedCrossRefGoogle Scholar
  3. Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C (2005) Early postmenopausal hormone replacement therapy may prevent cognitive impairment later in life. Menopause 12:12–17. doi: 10.1097/00042192-200512010-00005 PubMedCrossRefGoogle Scholar
  4. Brinton RD (2005) Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci 1052:57–74. doi: 10.1196/annals.1347.005 PubMedCrossRefGoogle Scholar
  5. Brinton RD, Tran J, Proffitt P, Montoya M (1997) 17 β-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22:1339–1351. doi: 10.1023/A:1022015005508 PubMedCrossRefGoogle Scholar
  6. Carlson MC, Zandi PP, Plassman BL et al (2001) Hormone replacement therapy and reduced cognitive decline in older women: the Cache County study. Neurology 57:2210–2216PubMedGoogle Scholar
  7. Daniel JM, Hulst JL, Berbling JL (2006) Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 147:607–614. doi: 10.1210/en.2005-0998 PubMedCrossRefGoogle Scholar
  8. Espeland MA, Rapp SR, Shumaker SA et al (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. JAMA 291:2959–2968. doi: 10.1001/jama.291.24.2959 PubMedCrossRefGoogle Scholar
  9. Frye CA, Duffy CK, Walf AA (2007) Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiol Learn Mem 88:208–216. doi: 10.1016/j.nlm.2007.04.003 PubMedCrossRefGoogle Scholar
  10. Fuh J-L, Wang S-J, Lee S-J, Lu S-R, Juang K-D (2006) A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 53:447–453. doi: 10.1016/j.maturitas.2005.07.009 PubMedCrossRefGoogle Scholar
  11. Geerlings MI, Launer LJ, de Jong FH et al (2003) Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 53:607–615. doi: 10.1002/ana.10521 PubMedCrossRefGoogle Scholar
  12. Gibbs RB (2000) Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 21:107–116. doi: 10.1016/S0197-4580(00)00103-2 PubMedCrossRefGoogle Scholar
  13. Grady D, Yaffe K, Kristof M et al (2002) Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med 113:543–548. doi: 10.1016/S0002-9343(02)01270-6 PubMedCrossRefGoogle Scholar
  14. Hao J, Rapp PR, Leffler AE et al (2006) Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 26:2571–2578. doi: 10.1523/JNEUROSCI.3440-05.2006 PubMedCrossRefGoogle Scholar
  15. Harman SM, Brinton EA, Cedars M et al (2005) KEEPS: the Kronos early estrogen prevention study. Climacteric 8:3–12. doi: 10.1080/13697130500042417 PubMedCrossRefGoogle Scholar
  16. Hemminki E, Malin M, Topo P (1993) Selection to postmenopausal therapy by women’s characteristics. J Clin Epidemiol 46:211–219. doi: 10.1016/0895-4356(93)90068-C PubMedCrossRefGoogle Scholar
  17. Henderson VW (2006) Estrogen-containing hormone therapy and Alzheimer’s disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138:1031–1039. doi: 10.1016/j.neuroscience.2005.06.017 PubMedCrossRefGoogle Scholar
  18. Henderson VW, Sherwin BB (2007) Surgical versus natural menopause: cognitive issues. Menopause 14:572–579. doi: 10.1097/gme.0b013e31803df49c PubMedCrossRefGoogle Scholar
  19. Henderson VW, Dudley EC, Guthrie JR, Burger HG, Dennerstein L (2003) Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60:1369–1371PubMedCrossRefGoogle Scholar
  20. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA (2005) Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76:103–105. doi: 10.1136/jnnp.2003.024927 PubMedCrossRefGoogle Scholar
  21. Herlitz A, Thilers P, Habib R (2007) Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 14:425–431. doi: 10.1097/01.gme.0000247019.86748.e3 PubMedCrossRefGoogle Scholar
  22. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J (2000) The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101:485–512. doi: 10.1016/S0306-4522(00)00410-3 PubMedCrossRefGoogle Scholar
  23. Johnson AB, Sohrabji F (2005) Estrogen’s effects on central and circulating immune cells vary with reproductive age. Neurobiol Aging 26:1365–1374. doi: 10.1016/j.neurobiolaging.2004.12.006 PubMedCrossRefGoogle Scholar
  24. Kang JH, Weuve J, Grodstein F (2004) Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 63:101–107PubMedGoogle Scholar
  25. Kok HS, Kuh D, Cooper R et al (2006) Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13:19–27. doi: 10.1097/01.gme.0000196592.36711.a0 PubMedCrossRefGoogle Scholar
  26. Markowska AL, Savonenko AV (2002) Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 22:10985–10995PubMedGoogle Scholar
  27. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1996) Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971–978PubMedGoogle Scholar
  28. Mitchell ES, Woods NF (2001) Midlife women’s attributions about perceived memory changes: observations from the Seattle Midlife Women’s Health Study. J Womens Health Gend Based Med 10:351–362. doi: 10.1089/152460901750269670 CrossRefGoogle Scholar
  29. Murphy DD, Segal M (1996) Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16:4059–4068PubMedGoogle Scholar
  30. Neugarten BL, Kraines RJ (1965) “Menopausal symptoms” in women of various ages. Psychosom Med 27:266–273PubMedGoogle Scholar
  31. Nilsen J, Brinton RD (2003) Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA 100:10506–10511. doi: 10.1073/pnas.1334098100 PubMedCrossRefGoogle Scholar
  32. Petanceska SS, Nagy G, Frail D, Gandy S (2000) Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain. Neurology 54:2212–2217PubMedGoogle Scholar
  33. Phillips SM, Sherwin BB (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485–495. doi: 10.1016/0306-4530(92)90007-T PubMedCrossRefGoogle Scholar
  34. Rapp PR, Morrison JH, Roberts JA (2003a) Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23:5708–5714PubMedGoogle Scholar
  35. Rapp SR, Espeland MA, Shumaker SA et al (2003b) The effect of estrogen with progestin treatment on global cognitive function in postmenopausal women: results from the Women’s Health Initiative Memory Study. JAMA 289:2663–2672. doi: 10.1001/jama.289.20.2663 PubMedCrossRefGoogle Scholar
  36. Resnick SM, Henderson VW (2002) Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288:2170–2172. doi: 10.1001/jama.288.17.2170 PubMedCrossRefGoogle Scholar
  37. Resnick SM, Maki PM, Rapp SR et al (2006) Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91:1802–1810. doi: 10.1210/jc.2005-2097 PubMedCrossRefGoogle Scholar
  38. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333. doi: 10.1001/jama.288.3.321 PubMedCrossRefGoogle Scholar
  39. Savonenko AV, Markowska AL (2003) The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 119:821–830. doi: 10.1016/S0306-4522(03)00213-6 PubMedCrossRefGoogle Scholar
  40. Schupf N, Winsten S, Patel B et al (2006) Bioavailable estradiol and age at onset of Alzheimer’s disease in postmenopausal women with Down syndrome. Neurosci Lett 406:298–302. doi: 10.1016/j.neulet.2006.07.062 PubMedCrossRefGoogle Scholar
  41. Sherwin BB, Tulandi T (1996) “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81:2545–2549. doi: 10.1210/jc.81.7.2545 PubMedCrossRefGoogle Scholar
  42. Shumaker SA, Legault C, Rapp SR et al (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study (WHIMS). JAMA 289:2651–2662. doi: 10.1001/jama.289.20.2651 PubMedCrossRefGoogle Scholar
  43. Shumaker SA, Legault C, Kuller L et al (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291:2947–2958. doi: 10.1001/jama.291.24.2947 PubMedCrossRefGoogle Scholar
  44. Singh M, Meyer EM, Millard WJ, Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644:305–312. doi: 10.1016/0006-8993(94)91694-2 PubMedCrossRefGoogle Scholar
  45. Stein DG (2008) Progesterone exerts neuroprotective effects after brain injury. Brain Res Brain Res Rev 57:386–397Google Scholar
  46. Tinkler GP, Tobin JR, Voytko ML (2004) Effects of two years estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol 469:507–521. doi: 10.1002/cne.11028 PubMedCrossRefGoogle Scholar
  47. Toran-Allerand CD (2000) Estrogen as treatment for Alzheimer disease. JAMA 284:307–308. doi: 10.1001/jama.284.3.307 PubMedCrossRefGoogle Scholar
  48. Toran-Allerand CD, Gerlach JL, McEwen BS (1980) Audiographic localization of [3H]estradiol related to steroid responsiveness in cultures of the newborn mouse hypothalamus and preoptic area. Brain Res 184:517–522. doi: 10.1016/0006-8993(80)90820-3 PubMedCrossRefGoogle Scholar
  49. Viscoli CM, Brass LM, Kernan WN et al (2005) Estrogen therapy and risk of cognitive decline: results from the Women’s Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 192:387–393. doi: 10.1016/j.ajog.2004.08.017 PubMedCrossRefGoogle Scholar
  50. Voytko ML (2002) Estrogen and the cholinergic system modulate visuospatial attention in monkeys. Behav Neurosci 116:187–197. doi: 10.1037/0735-7044.116.2.187 PubMedCrossRefGoogle Scholar
  51. Woolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12:2549–2554PubMedGoogle Scholar
  52. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women. JAMA 279:688–695. doi: 10.1001/jama.279.9.688 PubMedCrossRefGoogle Scholar
  53. Yaffe K, Vittinghoff E, Ensrud KE et al (2006) Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 63:945–950. doi: 10.1001/archneur.63.7.945 PubMedCrossRefGoogle Scholar
  54. Yue X, Lu M, Lancaster T et al (2005) Brain estrogen deficiency accelerates A(beta) plaque formation in an Alzheimer’s disease animal model. Proc Natl Acad Sci USA 102:19198–19203. doi: 10.1073/pnas.0505203102 PubMedCrossRefGoogle Scholar
  55. Zandi PP, Carlson MC, Plassman BL et al (2002) Hormone replacement therapy and incidence of Alzheimer’s disease on older women: the Cache County study. JAMA 288:2123–2129. doi: 10.1001/jama.288.17.2123 PubMedCrossRefGoogle Scholar

Copyright information

© American Aging Association, Media, PA, USA 2009

Authors and Affiliations

  1. 1.Department of Medicine and Geriatric Research, Education and Clinical Center (GRECC)University of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of Pharmacology and Pharmaceutical SciencesUniversity of Southern CaliforniaLos AngelesUSA
  3. 3.Departments of Health Research and Policy (Epidemiology) and of Neurology and Neurological SciencesStanford UniversityStanfordUSA
  4. 4.Harold and Margaret Milliken Hatch Laboratory of NeuroendocrinologyThe Rockefeller UniversityNew YorkUSA
  5. 5.Fishberg Department of NeuroscienceMount Sinai School of MedicineNew YorkUSA
  6. 6.Behavioral Endocrinology Branch, National Institute of Mental HealthNational Institutes of HealthBethesdaUSA

Personalised recommendations